A new study from the University of Virginia reveals that a widely used class of weight-loss drugs does more than suppress appetite-it directly alters brain circuits that control motivation and…

Involving a collaboration with 118 investigators contributing from 89 institutions, scientists from Queen Mary University of London's Precision Healthcare University Research Institute and Berlin Institute of Health (BIH) at Charité…

A type of drug used to prevent migraine may be associated with a reduced risk of glaucoma, according to a study published May 6, 2026, in Neurology®, the medical journal…

Non-concussive head impacts-hits to the head that don't cause clinically detectable symptoms-are correlated with subsequent changes to the gut microbiome in a small sample of US collegiate football players, according…

Among the challenges in treating disease, including cancer, is wiping out malignancies, infection, contaminants or other pathologies, without destroying healthy tissue.

The review offers important insights for patients and families by explaining why pancreatic cancer has proven so resistant to treatment, and where new hope may emerge.

Sarah Rutstein, MD, PhD, and Thibaut Davy‑Mendez, PhD, MSPH, with the Institute for Global Health and Infectious Diseases have received an R01 from the National Institute of Mental Health (NIMH)…

Researchers at The University of Texas MD Anderson Cancer Center and The University of Texas at Austin have identified specific blood-based genomic biomarkers that distinguish inflammatory breast cancer from other…

NYU Langone Health hospitals continued a six-year streak of top national recognition for patient safety and quality, joining just 1 percent of hospitals nationwide to receive 12 consecutive A grades…

Scientists are developing a test which could one day be used to predict how a patient's illness will progress, and even how well they will respond to treatment.